Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Bullboard Posts
Post by doubleLson Jan 23, 2018 8:16am
213 Views
Post# 27414113

Why is the Market Cap of this company still sub$200m?

Why is the Market Cap of this company still sub$200m?I've seen analysis posted on this board explaining all the rationale under the sun for why this should be trading at a minimum of $4.60 (2x current valuation) if not greater.  Little to no debt, actual earnings, growing production capacity that is very competitive to peers, etc...   

Is some of the issue simply marketing, not being 'cool'?  

Personally I think not having a strain 'brand', extremely poor website for AB Labs and possibly the set-up of the company being difficult for others to see as a takeover target (given that the company itselfs vision is to acquire undervalued companies).   Except how would it go about doing so without raising capital for these overvalued companies -- which it cant do fairly at current valuation without terrible dilution. 

So what's next?  

I'm VERY long, and heavily invested because I can't understand the current valuation despite the concerns above... but does anyone have thoughts on those issues I've addressed?

Thanks, 
Bullboard Posts